ACM

Aisling Capital Management Portfolio holdings

AUM $360M
This Quarter Return
-5.49%
1 Year Return
+114.67%
3 Year Return
+1,171.46%
5 Year Return
+892.24%
10 Year Return
AUM
$625M
AUM Growth
+$625M
Cap. Flow
+$106M
Cap. Flow %
16.96%
Top 10 Hldgs %
88.98%
Holding
21
New
6
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
BBIO icon
1
BridgeBio Pharma
BBIO
$9.89B
$370M 59.23%
6,068,125
ELEV
2
DELISTED
Elevation Oncology
ELEV
$38.5M 6.16%
+2,834,910
New +$38.5M
GLUE icon
3
Monte Rosa Therapeutics
GLUE
$296M
$33.4M 5.35%
+1,472,331
New +$33.4M
HRMY icon
4
Harmony Biosciences
HRMY
$2.12B
$23.8M 3.81%
842,815
NUVB icon
5
Nuvation Bio
NUVB
$1.02B
$23.7M 3.79%
2,541,009
SNDX icon
6
Syndax Pharmaceuticals
SNDX
$1.41B
$17.6M 2.82%
1,025,000
SPRB
7
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
$13.5M 2.16%
1,205,511
BMEA icon
8
Biomea Fusion
BMEA
$116M
$12.5M 2%
+798,757
New +$12.5M
SYRE icon
9
Spyre Therapeutics
SYRE
$996M
$11.8M 1.88%
1,691,151
ACRS icon
10
Aclaris Therapeutics
ACRS
$209M
$11.1M 1.78%
634,455
PSTX
11
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$10.5M 1.67%
1,043,267
TRML icon
12
Tourmaline Bio
TRML
$601M
$10M 1.61%
+682,923
New +$10M
TECX
13
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
$8.98M 1.44%
1,009,779
MRKR icon
14
Marker Therapeutics
MRKR
$12M
$8.77M 1.4%
3,142,857
VRNA
15
Verona Pharma
VRNA
$9.16B
$8.71M 1.4%
1,332,485
OKUR
16
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
$8.27M 1.32%
+886,075
New +$8.27M
OBSV
17
DELISTED
ObsEva SA Ordinary Shares
OBSV
$4.2M 0.67%
1,386,338
BCEL
18
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$3.3M 0.53%
387,653
VIRX
19
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$3.27M 0.52%
+288,571
New +$3.27M
ZSAN
20
DELISTED
Zosano Pharma Corporation
ZSAN
$2.58M 0.41%
2,718,226
NBRV
21
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$258K 0.04%
191,028